KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Accounts Payables: 2010-2024

Historic Accounts Payables for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $2.1 million.

  • TherapeuticsMD's Accounts Payables fell 28.50% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 28.50%. This contributed to the annual value of $2.1 million for FY2024, which is 32.11% down from last year.
  • TherapeuticsMD's Accounts Payables amounted to $2.1 million in FY2024, which was down 32.11% from $3.1 million recorded in FY2023.
  • TherapeuticsMD's Accounts Payables' 5-year high stood at $21.1 million during FY2020, with a 5-year trough of $2.1 million in FY2024.
  • For the 3-year period, TherapeuticsMD's Accounts Payables averaged around $8.0 million, with its median value being $3.1 million (2023).
  • As far as peak fluctuations go, TherapeuticsMD's Accounts Payables tumbled by 83.99% in 2021, and later spiked by 458.73% in 2022.
  • Over the past 5 years, TherapeuticsMD's Accounts Payables (Yearly) stood at $21.1 million in 2020, then plummeted by 83.99% to $3.4 million in 2021, then skyrocketed by 458.73% to $18.8 million in 2022, then crashed by 83.38% to $3.1 million in 2023, then slumped by 32.11% to $2.1 million in 2024.